Synergy of fosmidomycin (FR-31564) and other antimicrobial agents
Open Access
- 1 October 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 22 (4) , 560-563
- https://doi.org/10.1128/aac.22.4.560
Abstract
Fosmidomycin (FR-31564), a phosphonic acid derivative, was combined with cefazolin, cephalexin, ampicillin, carbenicillin, ticarcillin, gentamicin, and trimethoprim. Synergy between fosmidomycin and penicillins or cephalosporins was found for 37 to 52% of the Enterobacteriaceae tested. Synergy with trimethoprim was found against 55% of bacteria isolated, but only 17% of the strains showed synergy between formidomycin and gentamicin. Synergy between fosmidomycin and ticarcillin was shown for 35% of the Pseudomonas isolates. Cefazolin-, ampicillin-, and gentamicin-resistant isolates of various species were synergistically inhibited by fosmidomycin, as were ticarcillin- and gentamicin-resistant isolates. Antagonism was not encountered. This study illustrates another example of synergistic activity of compounds which attack different mechanisms in bacterial cells.This publication has 8 references indexed in Scilit:
- In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agentAntimicrobial Agents and Chemotherapy, 1981
- In vitro synergism of FR-31564, a new phosphonic acid antibiotic.The Journal of Antibiotics, 1981
- FR-31564, a new phosphonic acid antibiotic: Bacterial resistance and membrane permeability.The Journal of Antibiotics, 1980
- In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.The Journal of Antibiotics, 1980
- Interaction of fosfomycin with other antimicrobial agents: in vitro and in vivo studiesJournal of Antimicrobial Chemotherapy, 1978
- Synergism of Fosfomycin-Ampicillin and Fosfomycin-Chloramphenicol Against Salmonella and ShigellaAntimicrobial Agents and Chemotherapy, 1978
- Interactions of Fosfomycin with other AntibioticsChemotherapy, 1977
- Synergy of Mecillinam, a Beta-Amidinopenicillanic Acid Derivative, Combined with Beta-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 1976